Stay updated on AK104 Combo with Lenvatinib & TACE Clinical Trial
Sign up to get notified when there's something new on the AK104 Combo with Lenvatinib & TACE Clinical Trial page.

Latest updates to the AK104 Combo with Lenvatinib & TACE Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedNew revision v3.4.2 was added and v3.4.1 was removed; it includes changes to recruitment status, study status, and contacts/locations.SummaryDifference0.1%

- Check15 days agoChange DetectedAdded Revision: v3.4.1 to the record history and removed the generic funding notice; this is an administrative update.SummaryDifference0.9%

- Check22 days agoChange DetectedA notice about a lapse in government funding and the NIH Clinical Center's operating status was added to the page.SummaryDifference0.8%

- Check29 days agoChange DetectedThe page now displays color-coded highlights for changes (green for additions, red for deletions) and includes a glossary toggle. It also shows the latest revision version (v3.4.0) and removes the prior No FEAR Act data note.SummaryDifference1%

- Check36 days agoChange DetectedA new revision entry v3.3.4 was added to the study record history, and v3.3.3 is listed as a deletion, reflecting minor maintenance of the page history rather than changes to study content; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedA new history entry 'Revision: v3.3.3' was added to the record history, and the 'HHS Vulnerability Disclosure' link and 'Revision: v3.3.2' entry were removed from the footer.SummaryDifference0.2%

Stay in the know with updates to AK104 Combo with Lenvatinib & TACE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 Combo with Lenvatinib & TACE Clinical Trial page.